Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

被引：0
|
作者：
Takashi Seto
Naoyuki Nogami
Nobuyuki Yamamoto
Shinji Atagi
Naoki Tashiro
Yoko Yoshimura
Yutaka Yabuki
Hideo Saka
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] National Hospital Organization Shikoku Cancer Center,Department of Thoracic Oncology and Medicine
[3] Wakayama Medical University Hospital,Third Department of Internal Medicine
[4] National Hospital Organization Kinki-chuo Chest Medical Center,Department of Thoracic Oncology
[5] AstraZeneca K.K.,Medical Department
[6] National Hospital Organization Nagoya Medical Center,Department of Medical Oncology
来源：
Oncology and Therapy | 2018年 / 6卷 / 2期
关键词：
T790M; Epidermal growth factor receptor; Non-small-cell lung cancer; Osimertinib; Rebiopsy;
D O I：
10.1007/s40487-018-0064-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：203 / 215
页数：12
相关论文
共 50 条
  • [41] Real-world data on efficacy and safety of osimertinib in non-small cell lung cancer patients with EGFR T790M mutation detected by first and repeat rebiopsy
    Wang, Yuenan
    Zhang, Huanhuan
    Zou, Yuxia
    Ren, Xueru
    Wang, Hanqi
    Bai, Rubing
    Xu, Ke
    Xu, Yehong
    Zhang, Zhihong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 715 - 722
  • [42] Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer
    Kawamura, Takahisa
    Kenmotsu, Hirotsugu
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Omae, Katsuhiro
    Mori, Keita
    Tanigawara, Yusuke
    Nakajima, Takashi
    Ohde, Yasuhisa
    Endo, Masahiro
    Takahashi, Toshiaki
    CLINICAL LUNG CANCER, 2018, 19 (02) : E247 - E252
  • [43] ASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses
    Provencio, M.
    Cheema, P. K.
    Vansteenkiste, J. F.
    Cho, B. C.
    Zhou, C.
    Yu, J.
    Martin, C.
    Park, K.
    He, Y.
    Hu, Y.
    Vicente, D.
    Miranda, M.
    Rigas, J.
    de Marinis, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] Urine Detection of EGFR T790M Mutation in Non-Small-Cell Lung Cancer: An Outcomes and Total Cost of Care Analysis
    Sands, Jacob
    Hornberger, John
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1191 - S1191
  • [45] Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance
    Wang, Ying
    Liu, Qiuyun
    Chen, Haojie
    You, Jun
    Peng, Bin
    Cao, Fanfan
    Zhang, Xue
    Chen, Qing
    Uzan, Georges
    Xu, Limin
    Zhang, Denghai
    ANTI-CANCER DRUGS, 2018, 29 (08) : 748 - 755
  • [46] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status
    Nakashima, Kazuhisa
    Kimura, Madoka
    Akamatsu, Hiroaki
    Daga, Haruko
    Imai, Hisao
    Taira, Tetsuhiko
    Ko, Ryo
    Hisamatsu, Yasushi
    Nishino, Kazumi
    Sugimoto, Takeya
    Miyashita, Yosuke
    Takahashi, Toshiaki
    Kumagai, Toru
    Yamamoto, Nobuyuki
    Murakami, Haruyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 671 - 675
  • [47] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
    Akamatsu, Hiroaki
    Katakami, Nobuyuki
    Okamoto, Isamu
    Kato, Terufumi
    Kim, Young Hak
    Imamura, Fumio
    Shinkai, Masaharu
    Hodge, Rachel A.
    Uchida, Hirohiko
    Hida, Toyoaki
    CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
  • [48] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [49] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [50] The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
    Pan, Guoqiang
    Chen, Kaiyan
    Yu, Xiaoqing
    Sheng, Jiamin
    Fan, Yun
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2895 - 2905
12345